April 30th 2025
A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating various distribution models.
Disruptive Factors Shape RA Landscape
February 9th 2023As the range of treatment options for rheumatoid arthritis (RA) continues to grow and biosimilars are poised to enter the arena, the need for expert strategies to improve therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.